.png){kind=icon}
.png){kind=icon}
Return
Use of Statistics to Assess Serious Adverse Events in Clinical Trials of New Drugs: Cross-Sectional Study of FDA Review Memos
.png){kind=icon}
PRE
AI
S
P
T
W
L
C
J
DOI：10.1007/s11606-026-10556-7.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
IF:
4.2
Papers:
1.2W
Citations:
3.2W
Organization
Cited Papers